Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Watanabe

Showing results (341-350 of 424) with videos related to

Pageof 43
Sort By:
Atherosclerosis|February 2, 2016
Facilitatory effects of fetuin-A on atherosclerosisChisato Naito, Mio Hashimoto, Kaho Watanabe, et al.
The Tokai Journal of Experimental and Clinical Medicine|July 1, 2020
Myxofibrosarcoma that Developed Rapidly in the Breast of an Elderly Man and Recurred Early after Surgery: A Case ReportBanri Tsuda, Go Ogura, Nobue Kumaki, et al.
Oncotarget|February 23, 2018
A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinomaTadashi Sakane, Takayuki Murase, Katsuhiro Okuda, et al.
Endocrine Journal|March 29, 2021
Angiotensin receptor blockers significantly reduce hemoglobin level in patients with type 2 diabetes mellitus not suffered chronic cardiac failure and chronic kidney diseaseTakuya Watanabe, Yuichi Temma, Junichi Okada, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung CancerDe Hu, Hidetaka Yamada, Katsuhiro Yoshimura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 3, 2023
Coincidental items in the definition of metabolic dysfunction-associated fatty liver are useful in identifying patients having significant fibrosis with fatty liverKeisuke Kakisaka, Hidekatsu Kuroda, Tamami Abe, et al.
Journal of the American Heart Association|February 9, 2018
Neopterin Counters Vascular Inflammation and AtherosclerosisRemina Shirai, Kengo Sato, Tomoyuki Yamashita, et al.
Circulation|January 24, 2008
Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosisTakuya Watanabe, Kae Nishio, Tomoko Kanome, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanismKazuhide Hayakawa, Keiichi Irie, Kazunori Sano, et al.
Molecular and Clinical Oncology|July 7, 2018
The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancerKatsuhiro Okuda, Tsutomu Tatematsu, Motoki Yano, et al.
Pageof 43

Showing results (341-350 of 424) with videos related to

Sort By:
Pageof 43
Atherosclerosis|February 2, 2016
Facilitatory effects of fetuin-A on atherosclerosisChisato Naito, Mio Hashimoto, Kaho Watanabe, et al.
The Tokai Journal of Experimental and Clinical Medicine|July 1, 2020
Myxofibrosarcoma that Developed Rapidly in the Breast of an Elderly Man and Recurred Early after Surgery: A Case ReportBanri Tsuda, Go Ogura, Nobue Kumaki, et al.
Oncotarget|February 23, 2018
A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinomaTadashi Sakane, Takayuki Murase, Katsuhiro Okuda, et al.
Endocrine Journal|March 29, 2021
Angiotensin receptor blockers significantly reduce hemoglobin level in patients with type 2 diabetes mellitus not suffered chronic cardiac failure and chronic kidney diseaseTakuya Watanabe, Yuichi Temma, Junichi Okada, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung CancerDe Hu, Hidetaka Yamada, Katsuhiro Yoshimura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 3, 2023
Coincidental items in the definition of metabolic dysfunction-associated fatty liver are useful in identifying patients having significant fibrosis with fatty liverKeisuke Kakisaka, Hidekatsu Kuroda, Tamami Abe, et al.
Journal of the American Heart Association|February 9, 2018
Neopterin Counters Vascular Inflammation and AtherosclerosisRemina Shirai, Kengo Sato, Tomoyuki Yamashita, et al.
Circulation|January 24, 2008
Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosisTakuya Watanabe, Kae Nishio, Tomoko Kanome, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanismKazuhide Hayakawa, Keiichi Irie, Kazunori Sano, et al.
Molecular and Clinical Oncology|July 7, 2018
The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancerKatsuhiro Okuda, Tsutomu Tatematsu, Motoki Yano, et al.
Pageof 43